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AbstrACt
Objective To investigate the relationship between seafood 
consumption during pregnancy and the risk of delivering a 
small for gestational age (SGA) newborn.
Design This case–control study included women with 
SGA newborns and controls matched 1:1 for maternal age 
(±2 years) and hospital.
setting Five hospitals in Eastern Andalusia, Spain.
Participants 518 pairs of pregnant Spanish women. The 
SGA group included women who delivered SGA newborns: 
SGA was defined as a birth weight below the 10th 
percentile of infants at a given gestational age. Controls 
were women who delivered newborns with adequate birth 
weights.
Interventions We collected data on demographic 
characteristics, socioeconomic status, toxic habits and 
diet. Midwives administered a 137-item Food Frequency 
Questionnaire.
Outcome measures We calculated quintiles of seafood 
intake and applied conditional logistic regression to 
estimate ORs and 95% CIs.
results Shellfish intake more than once/week yielded 
a significant protective effect against an SGA newborn 
(OR 0.25, 95% CI 0.08 to 0.76, after adjusting for energy, 
educational level, smoking, prepregnancy body mass 
index, weight and a history of preterm or low birthweight 
newborn). The risk of an SGA newborn was lower among 
women who consumed >29 g/day fish compared with 
women who consumed ≤8 g (adjusted OR 0.63, 95% CI 
0.41 to 0.98; p=0.025 for a trend). Similarly, the risk of an 
SGA newborn was lower among women who consumed 
>1 g/day of marine n-3 polyunsaturated fatty acids 
compared with those who consumed ≤0.4 g/day (adjusted 
OR 0.58, 95% CI 0.38 to 0.90; p=0.025 for a trend).
Conclusion An average seafood intake of at least 29 g/
day during pregnancy, equivalent to 2–3 servings/week, 
reduced the risk of an SGA newborn, compared with an 
average seafood intake of less than 8 g/day.
IntrODuCtIOn 
Seafood is an important source of nutrients. It 
contains proteins, vitamin D, minerals (iodine 
and selenium), and essential n-3 long-chain 
polyunsaturated fatty acids (n-3 LCPUFAs). 
There are three categories of seafood: lean 
fish, fatty fish and shellfish (molluscs, crus-
taceans and cephalopods).1 It is well known 
that fatty fish and shellfish contain a higher 
content of n-3 LCPUFAs than lean fish.2–4 
N-3 LCPUFAs, such as docosahexaenoic 
acid (DHA) and eicosapentaenoic acid 
(EPA), pass through the placental circula-
tion. The intake of n-3 LCPUFAs during preg-
nancy affects fetal development and extends 
the gestation time.5 Moreover, n-3 LCPUFAs 
strongly affect fetal body composition.6 
Furthermore, a study conducted in Hong 
Kong reported that an average maternal 
consumption of 450 g of seafood per week 
during pregnancy could increase the IQ in 
the offspring.7
On the other hand, seafood is a source 
of contaminants. It contains dioxins, poly-
chlorinated biphenyls (PCBs)—which are 
mainly found in cod liver and fish oils8and 
methylmercury (MeHg). It was reported 
that low levels of MeHg are found in clams 
and mussels and high levels are found in 
tuna, sea bass, sea bream, monkfish, hake 
strengths and limitations of this study
 ► The sample was representative of a reference pop-
ulation of healthy pregnant women with uncom-
plicated gestation periods  who attended several 
Andalusian public hospitals.
 ► The case–control design allowed inclusion of a large 
number of small for gestational age (SGA) cases.
 ► We used previously established Spanish fetal growth 
curves to define the average size for gestational age, 
and we measured seafood consumption with a Food 
Frequency Questionnaire previously validated in the 
Spanish population.
 ► Spanish pregnant women had a relatively high fish 
intake (and shellfish intake) compared with pregnant 
women in other European countries.
 ► The control group was selected, based on ‘density 
sampling’, from the same hospitals that served the 
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and octopus.9 In addition, MeHg is generally present 
in large oily fish, it crosses the placenta and it can alter 
fetal neurodevelopment.10 Based on those findings, the 
European Food Safety Authority Scientific Committee 
recommended that fish/seafood species with high 
mercury contents should be limited in the daily diet, in 
general, and particularly during the gestational period 
in pregnancy.11
The quantities of n-3 LCPUFAs and the concentrations 
of chemicals and toxic pollutants differ in different types 
of fish and shellfish. Consequently, there is some confu-
sion about what amount of fish consumption would be 
suitable during pregnancy, to avoid damage from pollut-
ants.12 Therefore, the Spanish Agency for Consumer 
Affairs, Food Safety and Nutrition offered advice on 
the types of fish that should be consumed by pregnant 
women, as follows: ‘eat a wide variety of fish, but avoid 
contaminated species (eg, swordfish, fresh tuna, pike and 
shark)’. They also included a statement that advocated 
eating fish three to four times a week, primarily oily fish, 
such as anchovies, sardines or red mullet.13 14
In addition, the European Food Safety Authority Scien-
tific Committee recommended an intake of 1–4 servings 
of fish/week during pregnancy.11 Other international 
organisations have variously recommended: ≥1–2 serv-
ings/week to provide nearly 200 mg of n-3 LCPUFAs (eg, 
DHA and EPA)15–17; 2–3 servings/week from the ‘best 
choices’ list, such as clams, cod, crab or shrimp; or 1 
serving/week of the ‘good choices list’, such as monkfish 
and Spanish mackerel.18
Several longitudinal studies have evaluated the impact 
of maternal fish intake on the risk of small for gesta-
tional age (SGA) newborns. However, those studies have 
reported conflicting results; some reported positive 
effects,3 19 20 some reported mixed effects1 21 and others 
reported negative12 22–25 or null effects.26–28 Such incon-
sistencies might arise from differences in the types of fish 
assessed, which would lead to different contents of pollut-
ants and polyunsaturated n-3 fatty acids.21 Consequently, 
the relationships between fatty fish, lean fish or shellfish 
intake and the risk of having an SGA newborn remain 
unclear.
The present study aimed to determine how the 
consumption of different types of seafood during preg-
nancy affected the risk of having an SGA newborn.
MethODs
The study population included women who attended five 
hospitals in Eastern Andalusia (Spain): the University of 
Jaen Hospital (UJH), Ubeda Hospital, the University of 
Granada Hospitals (two centres) (UGH) and Poniente 
Hospital (PH). Taken together, these hospitals served 
1.8 million people. The SGA and control groups were 
recruited from 15 May 2012 to 15 July 2015. . 
We estimated the appropriate sample size, based on the 
results of a similar study.25 To detect a significant (p<0.05) 
OR of 0.6 between extreme quintiles with a statistical 
power of 80%, we estimated that 447 pairs of cases and 
controls were required.
sGA group
Tables previously developed for the Spanish population29 
classified SGA newborns as infants with birth weights 
below the 10th percentile of infants at the same gesta-
tional age. Mothers were eligible for the SGA group when 
they had delivered a single live SGA newborn with no 
congenital malformation during the study period; they 
had to reside in the referral area of the hospital and they 
had to have an adequate understanding of the Spanish 
language. Nineteen women declined participation. A 
total of 533 women were selected for the SGA case group, 
from the following hospitals: UJH (n=79), UGH (n=369), 
UH (n=46) and PH (n=39).
Control group
Within a week after including each woman in the SGA 
group, a woman of similar age at delivery (±2 years) 
was selected at the same hospital for the control group. 
Women eligible for the control group delivered a 
non-SGA newborn (birth weight above the 10th percen-
tile), but otherwise had to meet the same inclusion criteria 
required for the SGA group (residence in the referral 
area of the hospital, single pregnancy with no malforma-
tion and an adequate understanding of Spanish). Sixty-
five women declined participation.
Patient involvement
Patients were informed of the study by providing a written 
document of the characteristics and objectives of the 
study. The health professionals involved in the recruit-
ment and interview were available to clarify any doubts 
that might arise. Enrolled women were not involved in 
the recruitment of other participants. Personal identifica-
tion data were not obtained; therefore, the results of this 
observational study could not be disseminated back to the 
individual participants.
Data collection
We used three sources of data. First, personal interviews 
were conducted by midwives within 2 days after delivery. 
Second, we reviewed clinical charts. Third, we reviewed 
prenatal care records.
We collected the following data: Mother’s vital data, 
including age at pregnancy, race, education level, marital 
status, socioeconomic class and occupation; Obstetric 
history, including parity and abortions, previous adverse 
perinatal outcomes, and conditions during pregnancy 
(infections, pre-eclampsia, diabetes and other obstetric 
conditions); Birth weight measured (in grams) in 
the delivery room; drugs or medications, including 
prescribed drugs and over-the-counter medications; 
Social class, which included five main levels, ranging from 
I (the highest) to V (the lowest), according to the Spanish 
Society of Epidemiology classification system,30 which was 
close to that of the Black Report31; the Kessner Index, a 
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date of first visit)32 and toxic habits, including alcohol 
consumption during and before pregnancy (assessed 
with a structured questionnaire, which queried the 
number and type of drinks taken on weekdays, week-
ends, including Friday evening and holidays, including 
holiday eves); and smoking during pregnancy. The same 
data collection procedures were performed for SGA and 
control groups.
Dietary assessment
The midwives provided the Food Frequency Question-
naire (FFQ) to women after birth. The completion and 
return of the questionnaire confirmed participation in 
the study. The baseline questionnaire included a 137-item 
FFQ, previously validated in Spain, with open questions 
about the use of dietary supplements.33 34 The questions 
were based on typical portion sizes, and nine options 
described the frequency of intake in the previous year for 
each food item (range: never or almost never to ≥6 times/
day). For each FFQ food item, we estimated (1) the 
average amount of food consumed (grams) multiplied by 
the intake frequency; (2) the average total energy intake 
and (3) the average intake of macro and micronutrients, 
based on the latest available information from Spanish 
food composition tables.35 36 Additionally, we asked each 
woman whether she had modified her intake of any items 
on the FFQ due to her pregnancy (ie, lower, higher or 
unchanged intake).
Fish and shellfish were included in the FFQ, as follows: 
lean fish (hake, whiting, grouper, flounder, monkfish, 
cod); fatty fish (anchovies, sardines, salmon, mackerel, 
fresh or frozen tuna, swordfish); salted and smoked fish 
(herring, salmon, anchovies); canned fish (canned tuna, 
canned fish in oil) and three different types of shellfish 
(1) bivalve molluscs: oysters, clams, mussels; (2) crusta-
ceans: shrimp, prawns and (3) cephalopods: octopus, 
squid.
Seafood portion sizes were indicated in the FFQ, and the 
midwives were trained to give examples of portion sizes, as 
follows: 100–150 g for lean fish, 130 g for fatty fish, 60 g for 
salted and smoked fish, 50 g for canned fish (equivalent 
to a small can), 100–150 g for molluscs (six specimens), 
200 g for crustaceans (4–5 specimens) and 200 g for ceph-
alopods. The FFQ also asked whether supplements of n-3 
LCPUFAs were used; subjects included information about 
the product brand and the frequency of intake (range: 
never or almost never to ≥6 times/day).
After computing the total energy intake, we excluded 
15 matched pairs, due to unreliable dietary assessments 
(the total energy calculations indicated intakes above 
4000 kcal/day). Thus, 518 matched SGA and control 
pairs were included in the final analysis.
statistical analysis
Quantitative variables are expressed as the mean, SD 
and range, and frequencies are expressed in absolute 
and relative terms. The intake frequencies were derived 
from the FFQ; each respondent indicated intakes for the 
different types of seafood as: never; 1–3 servings/month; 
1 serving/week or >1 serving/week).
We used the residuals method to adjust food and 
nutrient intakes to the total energy intake, for the SGA 
and control groups in separates ways, as recommended 
previously.37 Nutrient intakes were stratified into quin-
tiles, according to intakes observed in controls (which 
represent the general population); thus, the quintile bins 
used to stratify the n-3 fatty acid and fish intakes in the 
control group were applied to intakes reported in the 
SGA group.
We implemented conditional logistic regression models 
to calculate crude ORs (cORs) and adjusted ORs (aORs) 
with their 95% CIs. The lowest quintile (Q1) was taken 
as the reference, and the main comparison was to the 
highest quintile (Q5). Trend analyses were performed 
with quintiles in logistic regression models, where the 
median intake for each quintile was introduced into 
the model. Intermediate variables were discarded, and 
to control for confounding variables, only variables that 
changed the diet coefficient by more than 10% were 
retained in the logistic models. A priori, we evaluated 
SGA risk factors in mothers that were related to diet (ie, 
tobacco use, pregestational body mass index (BMI), body 
weight, educational level, etc) as potential confounders. 
The model was adjusted for the following maternal 
factors: energy intake, educational level, smoking and 
pregestational BMI, and a previous preterm or low birth-
weight newborn. All p values are two tailed. Statistical 
significance was set at p<0.05. We repeated the analysis 
after including supplemental products that contained n-3 
LCPUFAs. We performed all analyses with Stata V.14.
results
Table 1 describes the characteristics of women included in 
the SGA and control groups. Marital status was different 
between the SGA and control groups. More women were 
married in the control group than in the SGA group 
(p<0.036). Previous preterm deliveries and low birthweight 
newborns were more frequent in the SGA group than in 
the control group (p<0.001). The SGA group included 
more women who smoked during pregnancy, more cases of 
pre-eclampsia and more women with intrauterine growth 
restriction during pregnancy than observed in the control 
group (p<0.001). The mean weight gain during pregnancy 
and the pregestational BMI were higher in the control 
group than in the SGA group (p<0.001).
Some items on the FFQ were modified by women during 
pregnancy. Fish intake was increased during pregnancy in 
27.03% of women in the SGA group and in 24.13% of the 
controls. Conversely, fish intake was reduced during preg-
nancy in 6.37% of women in the SGA group and in 6.76% 
of controls (p=0.563). At least a 50% increase in fish intake 
was reported by 5.6% of women in the SGA group and by 
4.8% of controls (p=0.862; data not shown in tables).
Table 2 shows the frequency of consumption of several 
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intake of lean fish (>1 serving/week) in the control group 
than in the SGA group. In the adjusted analysis, we found 
no significant association between the risk of SGA newborns 
and the intake of lean fish, fatty fish or salted fish. Never-
theless, more than once/week intakes of shellfish molluscs, 
such as clams, common cockles and mussels, yielded a lower 
risk of SGA newborns (aOR 0.25, 95% CI 0.08 to 0.76), even 
though the intakes of this particular type of seafood were 
infrequent. We found that the occasional intake of shellfish, 
cephalopods, squid and octopus conferred a slight protec-
tive effect against an SGA birth (no more than 3 servings/
month; aOR 0.62, 95% CI 0.44 to 0.87), but this association 
was not observed with more frequent intakes (ie, there 
was no trend). We also found that canned fish intake (>1/
week) had an overall protective effect, and this association 
was similar in the multivariable analysis, although not signif-
icant (aOR 0.64, 95% CI 0.37 to 1.13). Thus, canned fish 
with oil (the typical intake) was unrelated to the risk of an 
SGA newborn.
Table 3 shows the associations (ORs) between the risk 
of an SGA newborn and different daily intakes of seafood 
and marine n-3 fatty acids (g/day), stratified into quintiles. 
We found that a higher daily intake of seafood or marine 
n-3 fatty acids yielded significant protection against an SGA 
newborn. The OR of delivering an SGA newborn was lower 
with seafood intakes of >29 g/day (Q5; aOR 0.63, 95% CI 
0.41 to 0.98) compared with intakes of ≤8 g/day (Q1; 
p=0.025 for this trend). Moreover, the risk of having an 
SGA newborn was lower among women in Q5, with high 
daily intakes of marine n-3 fatty acids (>1 g/day; aOR 0.58, 
95% CI 0.38 to 0.90) than in the Q1 group (≤0.4 g/day; 
p=0.025 for the trend).
We also investigated whether the intake of n-3 LCPUFA 
supplements was related to the risk of an SGA newborn. We 
found that 8.7% of women in the SGA group and 6.2% of 
controls used these supplements. Among these, all but one 
woman used the same pharmaceutical brand (Natalben). 
The average daily intake was 200 mg. The cOR was 1.46 
(95% CI 0.91 to 2.37), and it remained unaltered after 
adjusting for confounders (aOR 1.51, 95% CI 0.90 to 2.52). 
The inclusion of these supplements in the multivariable 
analyses of fish and marine n-3 fatty acid intakes did not 
change the previous results.
DIsCussIOn
Our results demonstrated that the risk of having an SGA 
newborn was not consistently associated with the intakes 
of specific types of seafood (lean fish, fatty fish and shell-
fish) during pregnancy, when these types were addressed 
separately. However, when we considered the entire 
seafood intake during pregnancy, women in the highest 
quintile (Q5) had a lower risk of an SGA newborn than 
those in the lowest quintile (Q1). This result was rein-
forced, when we analysed the total intake of marine n-3 
fatty acids.
Table 1 Characteristics of the study population
Characteristic SGA group Controls P values
Marital status, n (%) 0.036
  Single 37 (7.1) 42 (8.1)
  Stable couple 161 (31.1) 124 (23.9)
  Married 320 (61.8) 352 (68.0)
Education level, n (%) 0.084
  Primary 112 (21.6) 93 (17.9)
  High school, not ended 42 (8.1) 28 (5.4)
  High school 185 (35.7) 190 (36.7)
  University 179 (34.6) 207 (40.0)
Previous preterm/low birthweight newborn, n (%) 64 (12.4) 26 (5.0) <0.001
Kessner Index (prenatal care), n (%) 0.737
  Adequate 259 (50.0) 253 (48.8)
  Intermediate 185 (35.7) 182 (35.2)
  Inadequate 74 (14.3) 83 (16.0)
Smoking during pregnancy, n (%) 149 (28.8) 80 (15.4) <0.001
Pre-eclampsia, n (%) 46 (8.9) 11 (2.1) <0.001
Intrauterine growth retardation, n (%) 141 (27.2) 8 (1.5) <0.001
Weight gain during pregnancy (g/week), mean (SD) 278 (121) 310 (114) <0.001
Pregestational body mass index, mean (SD) 23.1 (4.5) 23.9 (4.1) <0.001
Alcohol intake (g/week), mean (SD) 4.2 (18.5) 3.1 (15.2) 0.312
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One of the strengths of this study was the low likelihood 
that biases might have affected our findings. A selection bias 
was unlikely, because the number of women who refused 
to participate was rather small (3% for the SGA group and 
11% for the control group). Moreover, the FFQ used to 
measure, the diet was previously validated.33 34 This tool 
was acceptable, but some misclassification bias could not 
be ruled out. Nevertheless, the likelihood of a differential 
bias was low, because currently, there are no special recom-
mendations on seafood intake for women with intrauterine 
growth retardation, low weight gain during pregnancy, or 
signs of an SGA infant detected during obstetric explora-
tions (mainly ultrasonic scans). Another strength was that 
the controls were density matched to women in the SGA 
Table 2 Frequency of maternal intake of different seafood and ORs for the risk of an SGA infant
Intake frequency SGA group n (%) Controls n (%) cOR (95% CI) aOR* (95% CI)
Lean fish (100–150 g)
  Never 47 (9.1) 32 (6.2) 1 (ref.) 1 (ref.)
  1–3 a month 108 (20.9) 105 (20.3) 0.68 (0.40 to 1.15) 0.70 (0.39 to 1.26)
  1 a week 301 (58.1) 291 (56.2) 0.67 (0.41 to 1.09) 0.70 (0.41 to 1.20)
  >1 a week 62 (12.0) 90 (17.4) 0.45 (0.25 to 0.80) 0.53 (0.28 to 1.01)
Fatty fish (130 g)
  Never 77 (14.9) 73 (14.1) 1 (ref.) 1 (ref.)
  1–3 a month 130 (25.1) 113 (21.8) 1.09 (0.72 to 1.68) 1.22 (0.76 to 1.96)
  1 a week 258 (49.8) 263 (50.8) 0.93 (0.64 to 1.36) 0.96 (0.62 to 1.47)
  >1 a week 53 (10.2) 69 (13.3) 0.73 (0.45 to 1.19) 0.69 (0.40 to 1.20)
Salted-smoked fish (60 g)
  Never 312 (60.2) 321 (62.0) 1 (ref.) 1 (ref.)
  1–3 a month 149 (28.8) 125 (24.1) 1.21 (0.92 to 1.62) 1.28 (0.93 to 1.75)
  1+ a week 57 (11.0) 72 (13.9) 0.82 (0.56 to 1.21) 0.73 (0.48 to 1.11)
Shellfish-bivalves molluscs (6 units; 100–150 g)
  Never 183 (35.3) 162 (31.3) 1 (ref.) 1 (ref.)
  1–3 a month 228 (44.0) 228 (44.0) 0.88 (0.66 to 1.17) 0.90 (0.66 to 1.22)
  1 a week 102 (19.7) 113 (21.8) 0.77 (0.55 to 1.09) 0.73 (0.50 to 1.06)
  >1 a week 5 (1.0) 15 (2.9) 0.28 (0.10 to 0.80) 0.25 (0.08 to 0.76)
Shellfish-cephalopods (200 g)
  Never 149 (28.8) 116 (22.4) 1 (ref.) 1 (ref.)
  1–3 a month 237 (45.8) 282 (54.4) 0.61 (0.45 to 0.84) 0.62 (0.44 to 0.87)
  1+ a week 132 (25.5) 120 (23.2) 0.85 (0.60 to 1.20) 0.93 (0.64 to 1.37)
Shellfish-crustacean (4–5 units; 200 g)
  Never 164 (31.7) 144 (27.8) 1 (ref.) 1 (ref.)
  1–3 a month 256 (49.4) 279 (53.9) 0.80 (0.61 to 1.07) 0.85 (0.62 to 1.16)
  1+ a week 98 (18.9) 95 (19.3) 0.90 (0.62 to 1.29) 0.92 (0.62 to 1.37)
Canned fish-raw (small can; 50 g)
  Never 175 (33.8) 147 (28.4) 1 (ref.) 1 (ref.)
  1–3 a month 149 (28,8) 152 (29.3) 0.82 (0.60 to 1.14) 0.87 (0.62 to 1.24)
  1 a week 160 (30.9) 171 (33.0) 0.78 (0.58 to 1.07) 0.81 (0.58 to 1.12)
  >1 a week 34 (6.6) 48 (9.3) 0.57 (0.34 to 0.96) 0.64 (0.37 to 1.13)
Canned fish with oil (small can; 50 g)
Never 161 (31.1) 150 (29.0) 1 (ref.) 1 (ref.)
  1–3 a month 143 (27.6) 170 (32.8) 0.78 (0.57 to 1.08) 0.82 (0.58 to 1.16)
  1 a week 176 (34.0) 158 (30.5) 1.04 (0.76 to 1.42) 0.99 (0.71 to 1.38)
  >1 a week 38 (7.3) 40 (7.7) 0.89 (0.54 to 1.46) 1.00 (0.58 to 1.73)
*Adjusted for energy intake, educational level, smoking, pregestational BMI and previous preterm or low birthweight newborn.
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group; thus, seasonal influences on the responses to the 
FFQ were unlikely to affect our results, and a cohort effect 
on diet was avoided (younger women consumed a Western-
ised diet more frequently than older women). Moreover, 
age matching between cases and controls ensured that the 
reported preference for seafood among older women38 39 
would not alter the results. Therefore, any potential misclas-
sification bias was likely to be non-differential, which would 
cause an underestimation of the strength of an association, 
that is, when an association was observed in the data, the 
actual association was likely to be higher than that calcu-
lated. We also reduced biases due to confounding factors by 
collecting data on the most important determinants of SGA 
and considering them in multivariable analyses. However, 
this study also had some limitations. First, it was unlikely 
that our results were completely free of biases, and residual 
confounding could not be totally ruled out. Moreover, 
although we found that the total seafood intake and marine 
n-3 fatty acid intake were associated with a lower probability 
of delivering an SGA newborn, we could not demonstrate 
causality. However, some causality items were fulfilled, 
including, the strength of the association and consistency. 
Finally, our study was limited by the inability to adjust for 
environmental contaminants in the seafood.
One advantage of our study, which increased our statis-
tical power, was that the Spanish population has a rela-
tively high seafood intake, and a wide variety of species 
are typically included in the Spanish diet.40 41 Additionally, 
we found that, in our sample, women were more likely to 
increase, rather than decrease, fish intake during preg-
nancy. Nevertheless, in our study, a substantial proportion 
of women (about 30%) displayed little (1–3 servings/
month) or no seafood intake, which allowed us to assess 
whether dietary fish was associated with a lower risk of an 
SGA newborn. The use of n-3 LCPUFA supplements was 
scarce in our population (200 mg/day in Q2), much lower 
than the amounts consumed in the diet (>460 mg/day in 
Q2). It has been pointed out that supplements taken in 
the last half of the gestation period could provide a modest 
increase in measures at birth (eg, a higher birth weight) 
and reduce the probability of delivering before week 34.5 42 
Nevertheless, those reports remarked that most randomised 
trials of prenatal n-3 LCPUFA supplementation had been 
conducted in high-income countries, and therefore, the 
findings were not generalisable to populations in low-in-
come and middle-income settings.
Several previous studies have analysed the impact of 
seafood intake on the risk of delivering SGA newborns. Most 
studies were conducted with European cohorts,1 3 23 26 27 
but two were conducted in Spanish Mediterranean popu-
lations.20 21 The sample sizes of those studies ranged from 
657 women21 to 62 099 women.23 In general, almost all 
studies measured seafood intake with a validated FFQ, but 
the responses were collected at different times during preg-
nancy, that is, at the beginning of pregnancy,1 at mid-preg-
nancy3 19 21 23 26 27 43 and at birth22 25; the latter studies were 
conducted in Italian25 and Japanese women.22 However, 
many of those studies provided inconsistent results. In the 
present study, we collected all FFQ responses at birth.
The reported associations between the risk of an SGA 
newborn and seafood intake appeared to depend on the 
FFQ collection period. When the FFQ was completed at 
the beginning of pregnancy, for example, Halldorsson 
et al3 found that, among 44 824 Danish women, the risk of 
an SGA newborn was positively associated with more than 
4 servings of fatty fish/month. Similarly, in a cross-sectional 
study of Indian women with a low birthweight prevalence of 
20%, weekly fish consumption increased the risk of having 
a low birthweight infant by 26%.19 The Omega Study, 
conducted in Seattle Washington, showed that, in the 
Table 3 Associations between quintiles of daily seafood and marine n-3 fatty acids intakes and the birth of an SGA infant
Intake amounts (g/day) SGA group n (%) Controls n (%) OR (95% CI) OR* (95% CI)
Seafood intake
  Q1 (≤8) 129 (24.9) 104 (20.1) 1 (ref.) 1 (ref.)
  Q2 (8–14) 111 (21.4) 104 (20.1) 0.84 (0.57 to 1.22) 0.96 (0.63 to 1.46)
  Q3 (14–21.2) 108 (20.9) 103 (19.9) 0.83 (0.56 to 1.21) 0.94 (0.61 to 1.43)
  Q4 (21.2–29) 99 (19.1) 104 (20.1) 0.78 (0.53 to 1.15) 0.83 (0.54 to 1.28)
  Q5 (>29) 71 (13.7) 103 (19.9) 0.56 (0.38 to 0.84) 0.63 (0.41 to 0.98)
  P for trend 0.010 0.025
Marine n-3 fatty acids
  Q1 (≤0.4 g/day) 135 (26.1) 104 (20.1) 1 (ref.) 1 (ref.)
  Q2 (0.4–0.6) 105 (20.3) 104 (20.1) 0.79 (0.54 to 1.17) 0.88 (0.56 to 1.35)
  Q3 (0.6–0.7) 86 (16.6) 103 (19.9) 0.64 (0.43 to 0.95) 0.70 (0.45 to 1.09)
  Q4 (0.7–1) 116 (22.4) 104 (20.1) 0.86 (0.59 to 1.25) 0.93 (0.61 to 1.41)
  Q5 (>1) 76 (14.7) 103 (19.9) 0.58 (0.39 to 0.85) 0.58 (0.38 to 0.90)
  P for trend 0.028 0.024
*Adjusted for energy intake, educational level, smoking, pregestational BMI and previous preterm or low birthweight newborn.
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pregnancy cohort, higher intakes of shellfish (more than 
1 serving/week) and lean fish (more than 1 serving/week) 
were associated with a higher risk of low birth weight.43
Conversely, when the FFQ was completed at mid-preg-
nancy, a protective effect was found with seafood intake. 
One study in 62 099 Norwegian women showed that the 
relative risk of delivering a low birthweight baby (<2500 g) 
in full-term pregnancies was significantly lower in women 
who consumed >60 g/day of seafood than in women who 
consumed ≤5 g/day of seafood.23 Finally, an Italian retro-
spective case–control study (n=555 women) and a Turkish 
study (n=553 healthy pregnant women), reported that 
eating more fish reduced the odds of delivering an SGA 
newborn.25 44 However, those studies were limited by small 
numbers of SGA cases.
In our study, intakes of 2–3 seafood servings/week were 
observed two times as frequently in the control group as 
in the SGA group. This finding was supported by data 
from 19 European birth cohort studies, which showed that 
the average birth weight was 15.2 g higher (95% CI 8.9 to 
21.5 g) among women with a high fish intake during preg-
nancy (>3 servings/week) than among women with low 
fish intakes (<1 serving/week), independent of gestational 
age.12 Recently, a meta-analysis of the same data investi-
gated fish intake effects on the growth rate in infancy.24 
They found that, among mothers with high fish intakes 
(>3 serving/week) during pregnancy, the offspring BMI 
values were higher from infancy through middle childhood 
compared with offspring from mothers with low fish intakes 
(≤3 servings/week); this association was slightly stronger in 
female than in male newborns.
Other previous studies did not find any association 
between fish intake and the risk of an SGA newborn. This 
occurred in the study by Heppe et al27 in a sample of 3380 
pregnant women from Rotterdam, characterised by a low 
fish intake (median fish consumption, 75 g/week). Addi-
tionally, Drouillet et al26 found no association between a 
seafood intake of >2 servings/week before pregnancy and 
the risk of an SGA newborn in a sample of 1805 women 
from the French Eden mother–child cohort. However, 
among women with BMIs ≥25 kg/m2 in that cohort, women 
with pregestational seafood intakes of <5 servings/month 
had a threefold higher risk of an SGA newborn than women 
with intakes ≥9 servings/month.
Studies on specific types of seafood and the risk of SGA 
newborns have produced controversial results. For example, 
among Spanish women in Barcelona, canned tuna or crus-
tacean intakes >1 serving/week increased the risk of SGA 
newborns.20 Our results were inconsistent with the results 
of that study. In the Pelagie Cohort study, Guldner et al1 
studied a sample of 2398 French pregnant women. They 
found that 2 servings/week of fish and shellfish protected 
against SGA newborns; however, when considered individ-
ually, the effects were contradictory: fish reduced the risk, 
and shellfish increased the risk of SGA newborns. In our 
study, women who consumed more than 1 serving/week 
of bivalve molluscs had a lower risk of SGA newborns than 
women who consumed less than 1 serving/week. This 
finding might be explained by the rich content of vitamin 
B12 and fatty acids and the low percentage of heavy metals 
in molluscs.45 In addition, in the present case–control study, 
we observed that controls consumed more fatty fish, ceph-
alopod shellfish and canned fish during pregnancy than 
women with SGA newborns.
Some of the observed discrepancies between studies 
might be due to the different fish species considered. We 
did not find a consistent pattern of association between the 
risk of SGA newborns and the isolated fish types, except for 
bivalve molluscs. However, a protective effect was evident for 
seafood consumption, in general. This phenomenon was 
previously described in other studies on seafood consump-
tion in pregnancy1 and in studies that analysed the effect of 
a Mediterranean diet on cardiovascular risk: the overall diet 
pattern, but not any individual food, showed a preventive 
effect.46 We must consider that, in Spain, seafood intake is 
high and varied. Thus, an alternative type of seafood might 
compensate for low intake of a specific type of seafood, by 
contributing n3-fatty acids to the diet; for example, women 
with a low intake of molluscs might have a high intake 
of fatty fish and vice versa. This situation suggested that, 
instead of recommending the consumption of specific types 
of seafood during pregnancy, we should consider recom-
mending all seafood, except known contaminated species 
(ie, swordfish, fresh tuna, pike and shark). Thus, pregnant 
women should consume 3–4 servings of seafood (fish and 
shellfish)/week, as recommended,13 to protect against the 
risk of SGA newborns.
In summary, we found that an intake of at least 29 g/
day of seafood, or at least 1 g/day of n3-fatty acids, was 
observed nearly two times as frequently in controls than 
in women with SGA newborns. This finding suggested 
that an intake of 3–4 seafood servings/week, according 
to recommendations, could reduce the frequency of 
SGA newborns. In our sample, less than 20% of pregnant 
women followed this recommendation; therefore, a nutri-
tional educational intervention is required to target the 
general population, and specifically, pregnant women.
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This article was previously published with some errors.
 
In Table 3 in the quantity of quintiles of seafood intake (in grams), where it says:
Q1 (≤8); Q2 (8-14); Q3 (14-21.2); Q4 (21.2-29); Q5 (>29)
 
It should be:
Q1 (≤56); Q2 (56.1-74.0); Q3 (74.1-92.6); Q4 (92.7-121); Q5 (>121)
 
Considering this correction, some sections changes from the original published 
manuscript:
 
In the Abstract, in the result section, the sentence:
The risk of an SGA newborn was lower among women who consumed >29 g/day fish 
compared with women who consumed ≤8 g (adjusted OR 0.63, 95% CI 0.41 to 0.98; 
p=0.025 for a trend).
 
Should be:
The risk of an SGA newborn was lower among women who consumed >121 g/day fish 
compared with women who consumed ≤56 g (adjusted OR 0.63, 95% CI 0.41 to 0.98; 
p=0.025 for a trend).
 
In Abstract, in the conclusion, the sentence:
An average seafood intake of at least 29 g/ day during pregnancy, equivalent to 2–3 
servings/week, reduced the risk of an SGA newborn, compared with an average seafood 
intake of less than 8 g/day.
 
Should be:
An average seafood intake of at least 121 g/day during pregnancy, equivalent to 3–4 
servings/week, reduced the risk of an SGA newborn, compared with an average seafood 
intake of less than 56 g/day.
 
In the result section of the manuscript, in page 4, the sentence:
The OR of delivering an SGA newborn was lower with seafood intakes of >29 g/day 




The OR of delivering an SGA newborn was lower with seafood intakes of >121 g/day 




In summary, we found that an intake of at least 29 g/day of seafood, or at least 1 g/day 
of n3-fatty acids, was observed nearly two times as frequently in controls than in women 
with SGA newborns.
Correction





In summary, we found that an intake of at least 121 g/day of seafood, or at least 1 g/
day of n3-fatty acids, was observed nearly two times as frequently in controls than in 
women with SGA newborns.
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